CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,122 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04346342
NCT04346342N/ACompleted

PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) - an Observational Study of Invasively Ventilated Patients in the Netherlands

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)·observational·Posted Apr 15, 2020·Updated Jul 6, 2021

In Brief

An observational study for COVID and 2 related conditions. Completed, enrolled 1,122 participants across 22 sites.

Detailed Summary

The purpose of this national, multicenter service review is to determine and compare ventilation management in COVID-19 patients in the Netherlands, and to determine whether certain ventilation settings have an independent association with duration of ventilation. In every adult invasively ventilated COVID-19 patient from a participating ICU, granular ventilator settings and parameters will be collected from start of invasive ventilation for up to 72 hours. Follow up is until ICU and hospital discharge, and until day 90. The primary outcome includes main ventilator settings (including tidal volume, airway pressures, oxygen fraction and respiratory rate). Secondary endpoints are ventilator-free days and alive at day 28 (VFD-28); duration of mechanical ventilation; use of prone positioning and recruitment maneuvers; duration of ICU and hospital stay; incidence of kidney injury; and ICU, hospital, 28-day and 90-day mortality.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 15, 2020
Enrollment StartMar 6, 2020
Primary CompletionSep 1, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.2 years ago